/ / 161HI101
BG9928 in Subjects With Hepatic Impairment
Study Identifier161HI101
Clinicaltrials.gov
#NCT00858156Details
Development Status
Discontinued
Study Type
Interventional
Results Available
Yes
Study Dates
04/2009 - 08/2009
Enrollment
23
Study Drug
BG9928
Summary
The primary objective of the study is to evaluate the effect of hepatic function on the pharmacokinetics of a single oral dose of BG9928 in subjects with mild and moderate hepatic impairment and in subjects with normal hepatic function.
Study Results
View and download the Results Summaries with the results of this completed study.
CSR Synopsis
PDF Document
